Characterization of the Xenopus replication licensing system.
Chong
J P
JP
Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Herts, England.
Thömmes
P
P
Rowles
A
A
Mahbubani
H M
HM
Blow
J J
JJ
D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D002453:Cell Cycle / Q000502:physiology*; D018797:Cell Cycle Proteins / Q000302:isolation & purification / Q000378:metabolism*; D002467:Cell Nucleus / Q000187:drug effects / Q000502:physiology; D002474:Cell-Free System; D002498:Centrifugation; D002843:Chromatin / Q000502:physiology; D002850:Chromatography, Gel; D002852:Chromatography, Ion Exchange; D002853:Chromatography, Liquid; D004247:DNA / Q000032:analysis / Q000096:biosynthesis*; D004261:DNA Replication; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D005306:Fertilization; D007202:Indicators and Reagents; D008540:Meiosis; D008677:Metaphase; D008954:Models, Biological; D009865:Oocytes / Q000166:cytology / Q000502:physiology*; D011092:Polyethylene Glycols; D018741:Replication Origin; D015398:Signal Transduction; D013698:Templates, Genetic; D014982:Xenopus laevis
D018797:Cell Cycle Proteins; D002843:Chromatin; D004791:Enzyme Inhibitors; D007202:Indicators and Reagents; D011092:Polyethylene Glycols; C001020:N(6),N(6)-dimethyladenine; D004247:DNA; D000225:Adenine